Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 0.5% local lidocaine injection on prevention of acute postoperative pain
2022-000172-19Phase 4Active
- Sponsor
- Consorci Sanitari Integral
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lidocaine in acute postoperative pain and Persistent postsurgical pain (PPSP), sponsored by Consorci Sanitari Integral. Primary endpoint: Acute postoperative pain. Started Jun 2022; status: active.
02
Drugs
lidocaine
03
Conditions
acute postoperative painPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2022-000172-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000172-19.